Biogen Takes Nightstar Therapeutics for $877 Million

08.03.2019 - Biogen has agreed to acquire Nightstar Therapeutics, a clinical-stage gene therapy company based in London, UK. The US drug firm will pay Nightstar shareholders $25.50 for each...